New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Merck & Co., Inc.

MRK

Healthcare Drug Manufacturers General

Merck & Co., Inc.’s revenue for fiscal 2025 (year ended December 2025) was $65.0 billion, up 1.31% from fiscal 2024.

Revenue
+4.68%
EPS
−12.1%
Free cash flow
−19.3%
Total debt
+24.3%

Quarter to September 2026, against a year earlier

134.93 2.19 +1.65%
Market cap
$328.6B
P/E
137×
Fwd P/E FY26e
105×
Dividend yield
2.56%
F-score
4/9
ROIC
4.56%
Net debt / EBITDA
1.2×
Payout ratio
3.5×

Merck & Co., Inc. (MRK) EV/Sales

Alert me on EV/Sales

As of Nov 19, 2026, Merck & Co., Inc. (MRK) trades at a EV/Sales of 5.5×. Over the past ten years it has ranged from 3.3× (May 2025) to 6.5× (August 2026); the current reading is higher than 87% of that period. That is above the Drug Manufacturers General industry median of 4.1× and above the Healthcare sector median of 3.3×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 4.5× 6.99%
FY2024 4.2× (18.62%)
FY2023 5.2× 4.23%
FY2022 5.0× 12.69%
FY2021 4.4× (14.96%)
FY2020 5.2× (13.87%)
FY2019 6.1× 23.77%
FY2018 4.9× 22.21%
FY2017 4.0× (6.32%)
FY2016 4.3× 11.06%

Quarterly newest first

Period EV/Sales Change
Sep 2026 5.9× 9.01%
Jun 2026 5.4× 5.51%
Mar 2026 5.1× 13.16%
Dec 2025 4.5× 26.33%
43 more quarters

Against its own ten years

Low 3.3× High 6.5×
Ten-year median 4.7×
Current reading's percentile 86

EV/Sales against peers

Company EV/Sales
PFE Pfizer Inc. compare 3.2×
NVO Novo Nordisk A/S compare 3.6×
AZN AstraZeneca PLC compare 4.7×
MRK Merck & Co., Inc. 5.5×
NVS Novartis AG compare 5.6×
JNJ Johnson & Johnson compare 6.7×
AMGN Amgen Inc. compare 7.2×
GILD Gilead Sciences, Inc. compare 7.3×
ABBV AbbVie Inc. compare 8.7×
Drug Manufacturers General industry median 4.1×
Healthcare sector median 3.3×
Market median 2.0×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on MRK